Gilead Sciences, Inc. (GILD)
146.76
+0.64
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
146.50
-0.26
(-0.18%)
After-Hours: 20:00
Gilead Sciences Total Assets (Quarterly) : 49.36B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 49.36B |
| March 31, 2026 | 56.28B |
| December 31, 2025 | 59.02B |
| September 30, 2025 | 58.53B |
| June 30, 2025 | 55.72B |
| March 31, 2025 | 56.43B |
| December 31, 2024 | 59.00B |
| September 30, 2024 | 54.52B |
| June 30, 2024 | 53.58B |
| March 31, 2024 | 56.29B |
| December 31, 2023 | 62.12B |
| September 30, 2023 | 62.37B |
| June 30, 2023 | 62.34B |
| March 31, 2023 | 61.88B |
| December 31, 2022 | 63.17B |
| September 30, 2022 | 62.56B |
| June 30, 2022 | 62.87B |
| March 31, 2022 | 63.08B |
| December 31, 2021 | 67.95B |
| September 30, 2021 | 67.10B |
| June 30, 2021 | 67.98B |
| March 31, 2021 | 67.49B |
| December 31, 2020 | 68.41B |
| September 30, 2020 | 60.88B |
| June 30, 2020 | 55.93B |
| Date | Value |
|---|---|
| March 31, 2020 | 59.74B |
| December 31, 2019 | 61.63B |
| September 30, 2019 | 59.15B |
| June 30, 2019 | 63.21B |
| March 31, 2019 | 62.84B |
| December 31, 2018 | 63.68B |
| September 30, 2018 | 64.30B |
| June 30, 2018 | 65.36B |
| March 31, 2018 | 65.38B |
| December 31, 2017 | 70.28B |
| September 30, 2017 | 64.66B |
| June 30, 2017 | 60.26B |
| March 31, 2017 | 57.70B |
| December 31, 2016 | 56.98B |
| September 30, 2016 | 56.61B |
| June 30, 2016 | 49.98B |
| March 31, 2016 | 47.76B |
| December 31, 2015 | 51.72B |
| September 30, 2015 | 50.64B |
| June 30, 2015 | 39.17B |
| March 31, 2015 | 38.32B |
| December 31, 2014 | 34.66B |
| September 30, 2014 | 28.84B |
| June 30, 2014 | 31.21B |
| March 31, 2014 | 28.08B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 27.42B |
| AbbVie, Inc. | 135.12B |
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| Amgen, Inc. | 95.64B |
| Biogen, Inc. | 32.09B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 37.62B |
| Shareholders Equity (Quarterly) | 11.83B |
| Debt to Equity Ratio | 2.219 |
| Current Ratio | 1.266 |
| Net Debt Paydown Yield | -0.17% |